Author: News Room
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) — The “India Environmental Testing Market, By Region, Competition, Forecast & Opportunities, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.The India Environmental Testing Market was valued at USD 240.15 Million in 2024, and is expected to reach USD 378.18 Million by 2030, rising at a CAGR of 7.94%The Environmental Testing market in India is on an upswing due to increasing awareness about environmental degradation and the consequential enforcement of stringent environmental protection policies. This market includes diverse sectors such as pharmaceuticals, consumer goods, and industrial products, all of which require testing for compliance with…
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a class action was filed on behalf of all persons who purchased or sold Capri Holdings Limited (NYSE: CPRI) stock between August 10, 2023 and October 24, 2024. Capri is a fashion firm. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Capri Holdings Limited (CPRI) Misled Investors Regarding the Viability of its Acquisition by Tapestry, Inc. (TPR) According to the complaint, on August 10, 2023, Capri and Tapestry jointly…
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Micron Technology, Inc. (NASDAQ: MU) securities between September 28, 2023 and December 18, 2024. Micron designs, develops, manufactures, and sells memory and storage products, including, inter alia, dynamic random access memory (“DRAM”), NAND, NOR, and high-bandwidth memory (“HBM”) semiconductor devices. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Micron Technology, Inc. (MU)…
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Caribou Biosciences, Inc. (NASDAQ: CRBU) securities between July 14, 2023 and July 16, 2024. Caribou is a clinical-stage biopharmaceutical company that purports to develop genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the U.S. and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Caribou Biosciences, Inc. (CRBU) Misled…
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a class action was filed on behalf of purchasers of DMC Global Inc. (NASDAQ: BOOM) securities between May 3, 2024 and November 4, 2024. DMC Global is a diversified industrial company. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that DMC Global Inc. (BOOM) Misled Investors Regarding its Operations and Financial Results According to the complaint, during the class period, defendants failed to disclose that: (i) the goodwill associated with…
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (NASDAQ: BIOA) registration statement for the initial public offering (IPO) held on September 26, 2024. BioAge claims it is a “clinical stage biopharmaceutical company” that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating…
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) — The “Home Equity Lending Market Report 2024” has been added to ResearchAndMarkets.com’s offering.The home equity lending market size is expected to see steady growth in the next few years. It will grow to $34.73 billion in 2028 at a compound annual growth rate (CAGR) of 4.4%. The projected growth during the forecast period can be attributed to several factors, including the shift towards remote work, increasing real estate prices, a rise in home renovation activities, growth in residential properties, and higher disposable income. Key trends expected in this period include technological advancements and…
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) — The “Tonic-Clonic Seizures Treatment Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering.The tonic-clonic seizures treatment market was valued at USD 34.93 billion in 2023. The market is expected to grow at a CAGR of 6% during the period 2024-2032, reaching USD 55.84 billion by 2032. This growth is driven by the increased incidences of epilepsy across major regions, advancements in pharmaceutical research, rising awareness and diagnosis, and supportive government initiatives and investments in healthcare infrastructure. The United States leads the market due to advanced healthcare infrastructure, high awareness, and…
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) — The “Quantum Computing in Drug Discovery Market Report and Forecast 2024-2032” report has been added to ResearchAndMarkets.com’s offering.The global quantum computing in drug discovery market was valued at USD 400 million in 2023. The market is expected to grow at a CAGR of 13% during the period 2024-2032, reaching USD 1.20 billion by 2032 This growth is driven by the increasing adoption of artificial intelligence in the healthcare domain, advancements in quantum computing technology, rising investment from pharmaceutical companies, and supportive government policies and investments in healthcare research infrastructure. Quantum computing in drug…
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC (NASDAQ: AZN) securities between February 23, 2022 and December 17, 2024. AstraZeneca describes itself as “a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and Biopharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.” For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP…